Moderna | Le Coût Des Ventes



Cost Of Sales Changement Date
Acadia Pharmaceuticals USD 20.39M 1.41M 2025-03
Adcock Ingram Holdings ZAR 3.18B 115.21M 2024-12
Agios Pharmaceuticals USD 1.08M 175K 2025-03
Alnylam Pharmaceuticals USD 71.04M 31.78M 2025-03
Amgen USD 2.6B 507M 2025-03
Biogen USD 629.3M 45.8M 2025-03
BioMarin Pharmaceutical USD 151.56M 15.42M 2025-03
Celltrion KRW 399.04B 297.8B 2025-03
Cspc Pharmaceutical CNY 2.07B 71.26M 2024-09
Divis Laboratories Ltd 9.81B 590M 2025-03
Gilead Sciences USD 1.54B 41M 2025-03
GlaxoSmithKline GBP 1.92B 635M 2025-03
Incyte USD 67.8M 14.58M 2025-03
Ionis Pharmaceuticals USD 1000K 2.83M 2025-03
Kangmei Pharma CNY 1.21B 124.7M 2024-09
Knight Therapeutics CAD 47.25M 990K 2024-09
Laboratorios Farma EUR 152.05M 84.2M 2024-12
Malin Corporation EUR 15.4M 0 2020-12
Moderna USD 90M 456M 2025-03
Organigram Holdings CAD 41.68M 69.31M 2024-12
Pharma Mar EUR 3.4M 2.09M 2025-03
Qiagen NV USD 187.91M 16.67M 2024-12
Regeneron Pharmaceuticals USD 265.5M 299.9M 2025-03
Sarepta Therapeutics USD 137.56M 5.26M 2025-03
Sartorius EUR 452M 60.2M 2025-03
Sino Biopharmaceutical CNY 2.49B 1.07B 2024-12
Tilray USD 149.73M 9.39M 2024-11
Ultragenyx Pharmaceutical USD 28.66M 11.77M 2025-03
United Therapeutics USD 277.5M 201.6M 2025-03
Vertex Pharmaceuticals USD 423.4M 30.8M 2024-12
Zz Pientze Pharmaceu 1.73B 158.67M 2025-03



Moderna Le Coût Des Ventes - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - May 2025.